Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.03
+1.3%
$0.04
$0.03
$0.22
$905K-0.0937,303 shs80,879 shs
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
$0.15
-4.1%
$0.22
$0.13
$62.60
$3.81M-0.142.17 million shs3.90 million shs
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
$1.87
+2.2%
$2.57
$1.57
$27.20
$4.59M3.11.05 million shs76,291 shs
Nuwellis, Inc. stock logo
NUWE
Nuwellis
$0.99
+0.1%
$1.00
$0.75
$11.66
$4.33M0.51974,187 shs25,987 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
+1.33%-25.85%-16.02%-35.73%-25.85%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-3.63%-19.36%-8.49%-71.94%-99.73%
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
+2.19%-1.58%-20.43%-61.84%-53.30%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
0.00%-1.49%+10.00%-19.51%-88.79%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
1.7162 of 5 stars
0.05.00.00.03.31.70.6
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
0.358 of 5 stars
0.02.00.00.02.90.00.6
Nuwellis, Inc. stock logo
NUWE
Nuwellis
3.1629 of 5 stars
3.85.00.00.02.50.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00
N/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.00
N/AN/AN/A
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
0.00
N/AN/AN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
3.50
Strong Buy$17.001,617.17% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$7.16M0.13N/AN/A($0.03) per share-1.01
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/A$15.30 per shareN/A
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
$1.64M2.80N/AN/A$8.61 per share0.22
Nuwellis, Inc. stock logo
NUWE
Nuwellis
$8.74M0.50N/AN/A$18.40 per share0.05
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-$81.66MN/A0.00N/A-272.74%-311.64%-11.57%N/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-$7.10M-$56.60N/AN/AN/A-826.43%-707.26%5/21/2025 (Estimated)
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
-$6.66M-$6.27N/AN/A-514.01%-115.86%-105.40%5/13/2025 (Estimated)
Nuwellis, Inc. stock logo
NUWE
Nuwellis
-$20.21M-$38.53N/AN/AN/A-169.54%-28,159.25%-207.24%5/13/2025 (Estimated)

Latest AFIB, LUCY, NUWE, and GCTK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Nuwellis, Inc. stock logo
NUWE
Nuwellis
-$0.45N/AN/AN/A$2.50 millionN/A
3/24/2025Q4 2024
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
-$1.16-$0.41+$0.75-$0.41$1.00 million$1.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/AN/A
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
N/AN/AN/AN/AN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/A
1.85
1.57
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/A
0.14
0.14
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
N/A
16.83
15.22
Nuwellis, Inc. stock logo
NUWE
Nuwellis
N/A
2.03
1.34

Institutional Ownership

CompanyInstitutional Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
56.91%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
10.92%
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
0.96%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
3.13%

Insider Ownership

CompanyInsider Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
5.21%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
46.50%
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
6.42%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
1.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
34029.78 million28.23 millionOptionable
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
525.59 million5.57 millionNot Optionable
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
92.45 million2.29 millionNot Optionable
Nuwellis, Inc. stock logo
NUWE
Nuwellis
704.37 million4.26 millionNot Optionable

Recent News About These Companies

Nuwellis (NUWE) to Release Quarterly Earnings on Tuesday
Nuwellis price target lowered to $13 from $16 at Roth MKM
Nuwellis Appoints John Erb as Interim CEO
Nuwellis CEO Nestor Jaramillo retires, John Erb named interim CEO

New MarketBeat Followers Over Time

Media Sentiment Over Time

Acutus Medical stock logo

Acutus Medical NASDAQ:AFIB

$0.03 +0.00 (+1.33%)
As of 05/12/2025 03:45 PM Eastern

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

GlucoTrack stock logo

GlucoTrack NASDAQ:GCTK

$0.15 -0.01 (-4.06%)
Closing price 05/12/2025 04:00 PM Eastern
Extended Trading
$0.15 0.00 (-1.82%)
As of 05/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Innovative Eyewear stock logo

Innovative Eyewear NASDAQ:LUCY

$1.87 +0.04 (+2.19%)
Closing price 05/12/2025 04:00 PM Eastern
Extended Trading
$1.86 -0.01 (-0.48%)
As of 05/12/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

Nuwellis stock logo

Nuwellis NASDAQ:NUWE

$0.99 +0.00 (+0.12%)
Closing price 05/12/2025 03:58 PM Eastern
Extended Trading
$1.01 +0.02 (+2.53%)
As of 05/12/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.